Identification of Interconnected Markers for T-Cell Acute Lymphoblastic Leukemia

T-cell acute lymphoblastic leukemia (T-ALL) is a complex disease, resulting from proliferation of differentially arrested immature T cells. The molecular mechanisms and the genes involved in the generation of T-ALL remain largely undefined. In this study, we propose a set of genes to differentiate individuals with T-ALL from the nonleukemia/healthy ones and genes that are not differential themselves but interconnected with highly differentially expressed ones. We provide new suggestions for pathways involved in the cause of T-ALL and show that network-based classification techniques produce fewer genes with more meaningful and successful results than expression-based approaches. We have identified 19 significant subnetworks, containing 102 genes. The classification/prediction accuracies of subnetworks are considerably high, as high as 98%. Subnetworks contain 6 nondifferentially expressed genes, which could potentially participate in pathogenesis of T-ALL. Although these genes are not differential, they may serve as biomarkers if their loss/gain of function contributes to generation of T-ALL via SNPs. We conclude that transcription factors, zinc-ion-binding proteins, and tyrosine kinases are the important protein families to trigger T-ALL. These potential disease-causing genes in our subnetworks may serve as biomarkers, alternative to the traditional ones used for the diagnosis of T-ALL, and help understand the pathogenesis of the disease.

[1]  M. Greaves,et al.  Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia , 1987, Nature.

[2]  Lodewyk F. A. Wessels,et al.  A Critical Evaluation of Network and Pathway-Based Classifiers for Outcome Prediction in Breast Cancer , 2011, PloS one.

[3]  Peter Marynen,et al.  Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). , 2005, Blood.

[4]  G. Gamble,et al.  Chromosome 4q31 locus in COPD is also associated with lung cancer , 2010, European Respiratory Journal.

[5]  Doheon Lee,et al.  Inferring Pathway Activity toward Precise Disease Classification , 2008, PLoS Comput. Biol..

[6]  R. Foà,et al.  Myeloid/T-cell acute lymphoblastic leukemia in children and adults , 2011, Pediatric reports.

[7]  Y. Mo,et al.  Targeting Ubc9 for cancer therapy , 2005, Expert opinion on therapeutic targets.

[8]  F. Staal,et al.  The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis , 2008, European journal of immunology.

[9]  C. Sawyers,et al.  Targeted cancer therapy , 2004, Nature.

[10]  A. Borkhardt,et al.  The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21) , 2003, Oncogene.

[11]  P. Marynen,et al.  Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. , 2002, Cancer research.

[12]  W. Bal,et al.  Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. , 2006, Toxicology letters.

[13]  Expression of P2X7 receptor increases in vivo tumor growth. , 2012, Cancer research.

[14]  A. Noël,et al.  Enhanced Activity of Meprin-α, a Pro-Migratory and Pro-Angiogenic Protease, in Colorectal Cancer , 2011, PloS one.

[15]  R. Coutinho-Silva,et al.  Extracellular ATP induces cell death in human intestinal epithelial cells. , 2012, Biochimica et biophysica acta.

[16]  Trey Ideker,et al.  An Integrated Systems Analysis Implicates EGR1 Downregulation in Simian Immunodeficiency Virus Encephalitis-Induced Neural Dysfunction , 2009, The Journal of Neuroscience.

[17]  Xiaoyan Song,et al.  Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia , 2010, Hematology.

[18]  E. Petricoin,et al.  Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  H. Nakauchi,et al.  Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b+/F4/80+ myeloid cell recruitment , 2012, Leukemia.

[20]  S. Loh The missing zinc: p53 misfolding and cancer. , 2010, Metallomics : integrated biometal science.

[21]  Yusuke Nakamura,et al.  Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma. , 2002, International journal of oncology.

[22]  E. Raetz,et al.  Molecular pathogenesis of T-cell leukaemia and lymphoma , 2008, Nature Reviews Immunology.

[23]  G. Gordon,et al.  Phase 1 Study of ABT-751, a Novel Microtubule Inhibitor, in Patients with Refractory Hematologic Malignancies , 2005, Clinical Cancer Research.

[24]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Juliano,et al.  Clinging to life: cell to matrix adhesion and cell survival , 2005, Cancer and Metastasis Reviews.

[26]  M. Gerstein,et al.  Relating whole-genome expression data with protein-protein interactions. , 2002, Genome research.

[27]  P. Marynen,et al.  Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. , 2005, Haematologica.

[28]  H. Ploegh,et al.  Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Löwenberg,et al.  A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects. , 2009, Blood.

[30]  Z. Estrov,et al.  SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability , 2010, Oncogene.

[31]  L. Romer,et al.  Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. , 1996, Molecular biology of the cell.

[32]  G. Rubanyi,et al.  Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors , 2004, BMC Cancer.

[33]  A. Maitra,et al.  Aberrant methylation of the human hedgehog interacting protein (HHIP) gene in pancreatic neoplasms , 2005, Cancer biology & therapy.

[34]  J. Raser,et al.  Noise in Gene Expression: Origins, Consequences, and Control , 2005, Science.

[35]  Pall I. Olason,et al.  A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.

[36]  Ron Shamir,et al.  EXPANDER – an integrative program suite for microarray data analysis , 2005, BMC Bioinformatics.

[37]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  F. Sigaux,et al.  HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). , 2005, Blood.

[39]  Yi Zhang,et al.  Leukaemic transformation by CALM–AF10 involves upregulation of Hoxa5 by hDOT1L , 2006, Nature Cell Biology.

[40]  Shi-Hua Zhang,et al.  Detecting disease associated modules and prioritizing active genes based on high throughput data , 2010, BMC Bioinformatics.

[41]  L. Zitvogel,et al.  Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer , 2012, Oncoimmunology.

[42]  E. Sterchi,et al.  Activation of Human Meprin-α in a Cell Culture Model of Colorectal Cancer Is Triggered by the Plasminogen-activating System* , 2002, The Journal of Biological Chemistry.

[43]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[44]  E. Lander,et al.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.

[45]  Robert Clarke,et al.  Identifying protein interaction subnetworks by a bagging Markov random field-based method , 2012, Nucleic acids research.

[46]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Neil O. Carragher,et al.  The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.

[48]  M. Malavolta,et al.  Zinc-binding proteins (metallothionein and α-2 macroglobulin) and immunosenescence , 2006, Experimental Gerontology.

[49]  E. Macintyre,et al.  CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes , 2005, Leukemia.

[50]  Yun Li,et al.  Dynamic modular architecture of protein-protein interaction networks beyond the dichotomy of ‘date' and ‘party' hubs , 2013, Scientific Reports.

[51]  F. Staal,et al.  Signaling pathways involved in the development of T-cell acute lymphoblastic leukemia , 2008, Haematologica.

[52]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[53]  M. Schlesinger,et al.  The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives. , 1996, Leukemia.

[54]  Xiao-tong Ma,et al.  Expression of P2X7 in human hematopoietic cell lines and leukemia patients. , 2004, Leukemia research.

[55]  Torsten Haferlach,et al.  Modern diagnostics in acute leukemias. , 2005, Critical reviews in oncology/hematology.

[56]  A. Yakovlev,et al.  How high is the level of technical noise in microarray data? , 2007, Biology Direct.

[57]  David Warde-Farley,et al.  Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.

[58]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[59]  TaeHyun Hwang,et al.  Learning on Weighted Hypergraphs to Integrate Protein Interactions and Gene Expressions for Cancer Outcome Prediction , 2008, 2008 Eighth IEEE International Conference on Data Mining.

[60]  K. Ohshima,et al.  Elevated expression of CCL5/RANTES in adult T‐cell leukemia cells: Possible transactivation of the CCL5 gene by human T‐cell leukemia virus type I tax , 2004, International journal of cancer.

[61]  W. Hiddemann,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Global approach to the diagnosis of leukemia using gene expression profiling , 2022 .

[62]  A. Aderem Systems Biology: Its Practice and Challenges , 2005, Cell.

[63]  U. Ertem,et al.  High Prevelance of Chronic Magnesium Deficiency in T Cell Lymphoblastic Leukemia and Chronic Zinc Deficiency in Children with Acute Lymphoblastic Leukemia and Malignant Lymphoma , 2000, Leukemia & lymphoma.

[64]  J. S. Bond,et al.  Meprins, membrane-bound and secreted astacin metalloproteinases. , 2008, Molecular aspects of medicine.

[65]  Ka Yee Yeung,et al.  The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data. , 2009, Blood.

[66]  J. Cigudosa,et al.  NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15). , 2003, Cancer research.

[67]  R. Letón,et al.  Tumoral and tissue‐specific expression of the major human β‐tubulin isotypes , 2010, Cytoskeleton.

[68]  F. Di Virgilio,et al.  Expression of the P2X7 Receptor Increases the Ca2+ Content of the Endoplasmic Reticulum, Activates NFATc1, and Protects from Apoptosis* , 2009, Journal of Biological Chemistry.

[69]  O. Louthan Chromogranin a in physiology and oncology. , 2011, Folia biologica.

[70]  Y. Tu,et al.  Quantitative noise analysis for gene expression microarray experiments , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[71]  G. Eby Treatment of acute lymphocytic leukemia using zinc adjuvant with chemotherapy and radiation--a case history and hypothesis. , 2005, Medical hypotheses.

[72]  D. Goldenberg,et al.  Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers , 2007, BMC Cancer.

[73]  J. Rey,et al.  Human hedgehog interacting protein expression and promoter methylation in medulloblastoma cell lines and primary tumor samples , 2011, Journal of Neuro-Oncology.

[74]  Benno Schwikowski,et al.  Discovering regulatory and signalling circuits in molecular interaction networks , 2002, ISMB.

[75]  M. Vidal A Biological Atlas of Functional Maps , 2001, Cell.

[76]  A. Joe,et al.  Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy , 2006, Nature Clinical Practice Oncology.

[77]  C. Moreno The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways. , 2010, The American journal of pathology.

[78]  Z. Fishelson,et al.  Complement resistance of tumor cells: basal and induced mechanisms. , 1999, Molecular immunology.

[79]  Jingchun Chen,et al.  Detecting functional modules in the yeast protein-protein interaction network , 2006, Bioinform..

[80]  Shanghua Yin,et al.  Human Mutations That Confer Paclitaxel Resistance , 2010, Molecular Cancer Therapeutics.

[81]  Trey Ideker,et al.  Testing for Differentially-Expressed Genes by Maximum-Likelihood Analysis of Microarray Data , 2000, J. Comput. Biol..

[82]  J. S. Bond,et al.  Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer , 2005, FEBS letters.

[83]  O. Yokosuka,et al.  Down-Regulation of Hedgehog-Interacting Protein through Genetic and Epigenetic Alterations in Human Hepatocellular Carcinoma , 2008, Clinical Cancer Research.

[84]  A. Hagemeijer,et al.  Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast , 2006, Leukemia.

[85]  M. Malavolta,et al.  Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. , 2006, Experimental Gerontology.

[86]  Yang Chen,et al.  Open Access Research Article Identification of Responsive Gene Modules by Network-based Gene Clustering and Extending: Application to Inflammation and Angiogenesis , 2022 .

[87]  Torsten Haferlach,et al.  An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase , 2008, British journal of haematology.

[88]  Lan V. Zhang,et al.  Evidence for dynamically organized modularity in the yeast protein–protein interaction network , 2004, Nature.

[89]  Rod K. Nibbe,et al.  Approaches to biomarkers in human colorectal cancer: looking back, to go forward. , 2009, Biomarkers in medicine.

[90]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[91]  A. Statnikov,et al.  The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. , 2010, Cancer cell.

[92]  M. Elghetany,et al.  CD36: a multiligand molecule. , 2005, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

[93]  Haidong Wang,et al.  Discovering molecular pathways from protein interaction and gene expression data , 2003, ISMB.

[94]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[95]  M. Ranson,et al.  Plasminogen binding and cancer: promises and pitfalls. , 2003, Frontiers in bioscience : a journal and virtual library.

[96]  Nir Friedman,et al.  Tissue classification with gene expression profiles. , 2000 .

[97]  J. Singer,et al.  A functional defect in irradiated adherent layers from chronic myelogenous leukemia long-term marrow cultures. , 1985, Experimental hematology.

[98]  Ian H. Witten,et al.  The WEKA data mining software: an update , 2009, SKDD.

[99]  G. Basso,et al.  CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease , 2004, Leukemia.

[100]  Z. Fishelson,et al.  Phosphorylation of the complement component, C9, by an ecto-protein kinase of human leukemic cells. , 1999, Immunopharmacology.

[101]  J. Collins,et al.  A network biology approach to prostate cancer , 2007, Molecular systems biology.

[102]  G. Gordon,et al.  Phase1Study of ABT-751, a NovelMicrotubule Inhibitor, in Patients with Refractory HematologicMalignancies , 2005 .

[103]  Michael Recce,et al.  Noise filtering and nonparametric analysis of microarray data underscores discriminating markers of oral, prostate, lung, ovarian and breast cancer , 2004, BMC Bioinformatics.

[104]  A. Ferrando,et al.  Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia , 2004, Nature Genetics.

[105]  E. Dougherty,et al.  Accurate and Reliable Cancer Classification Based on Probabilistic Inference of Pathway Activity , 2009, PloS one.

[106]  J. Wiley,et al.  A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study , 2002, The Lancet.

[107]  T. Marafioti,et al.  Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissues. , 2009, Pathology, research and practice.

[108]  T. Lebien,et al.  Contact between human bone marrow stromal cells and B lymphocytes enhances very late antigen-4/vascular cell adhesion molecule-1-independent tyrosine phosphorylation of focal adhesion kinase, paxillin, and ERK2 in stromal cells. , 1997, Blood.

[109]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[110]  F. Di Virgilio,et al.  P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. , 2002, Blood.

[111]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[112]  L. Padyukov,et al.  Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia , 2002, The Lancet.

[113]  Jing Wang,et al.  PQN and DQN: algorithms for expression microarrays. , 2006, Journal of theoretical biology.

[114]  Emmanuel Barillot,et al.  Classification of microarray data using gene networks , 2007, BMC Bioinformatics.

[115]  M. Schaller,et al.  FAK regulates biological processes important for the pathogenesis of cancer , 2003, Cancer and Metastasis Reviews.

[116]  T. Hoang,et al.  The T-ALL paradox in cancer , 2010, Nature Medicine.

[117]  R. Pieters,et al.  Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia , 2008, British journal of haematology.

[118]  Serban Nacu,et al.  Gene expression network analysis and applications to immunology , 2007, Bioinform..

[119]  F. Di Virgilio,et al.  A His-155 to Tyr Polymorphism Confers Gain-of-Function to the Human P2X7 Receptor of Human Leukemic Lymphocytes1 , 2005, The Journal of Immunology.

[120]  S. Shurtleff,et al.  Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.